Thymus and Activation-regulated Chemokine as a Biomarker for IgG4-related Disease

[1]  M. Falconi,et al.  Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease. , 2019, Clinical and experimental rheumatology.

[2]  J. Stone,et al.  An International Multispecialty Validation Study of the IgG4‐Related Disease Responder Index , 2018, Arthritis care & research.

[3]  L. Criswell,et al.  2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts , 2017, Arthritis & rheumatology.

[4]  L. Criswell,et al.  2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome , 2016, Annals of the rheumatic diseases.

[5]  R. Morita,et al.  Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease , 2016, Arthritis Research & Therapy.

[6]  O. Matsui,et al.  IgG4-Related Disease: Dataset of 235 Consecutive Patients , 2015, Medicine.

[7]  J. Stone,et al.  Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations , 2014, Annals of the rheumatic diseases.

[8]  J. Stone,et al.  De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. , 2014, The Journal of allergy and clinical immunology.

[9]  K. Tsubota,et al.  Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan , 2014, Modern rheumatology.

[10]  Y. Kataoka.  Thymus and activation‐regulated chemokine as a clinical biomarker in atopic dermatitis , 2014, The Journal of dermatology.

[11]  J. Stone,et al.  Circulating Th2 memory cells in IgG4‐related disease are restricted to a defined subset of subjects with atopy , 2014, Allergy.

[12]  K. Okazaki,et al.  Comprehensive Diagnostic Criteria for IgG4-Related Disease , 2014 .

[13]  Y. Kubo,et al.  Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease , 2012, Annals of the rheumatic diseases.

[14]  J. Stone,et al.  IgG4-related disease. , 2012, The New England journal of medicine.

[15]  T. Hibi,et al.  Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 , 2012, Modern rheumatology.

[16]  K. Tsubota,et al.  A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details , 2011, Modern rheumatology.

[17]  Y. Kubo,et al.  Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. , 2012, Arthritis and rheumatism.

[18]  Y. Nakanuma,et al.  IgG4-Related Disease: A Cross-sectional Study of 114 Cases , 2010, The American journal of surgical pathology.

[19]  Y. Okamoto,et al.  Role of Th2 Cells in IgG4-Related Lacrimal Gland Enlargement , 2010, International Archives of Allergy and Immunology.

[20]  H. Sugimura,et al.  IgG4-related lung disease in a worker occupationally exposed to asbestos. , 2010, Internal medicine.

[21]  T. Kamisawa,et al.  Allergic manifestations in autoimmune pancreatitis , 2009, European journal of gastroenterology & hepatology.

[22]  H. Hammad,et al.  Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC‐derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation , 2009, Allergy.

[23]  T. Rispens,et al.  Immunoglobulin G4: an odd antibody , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  N. Fazilleau,et al.  Follicular helper T cells: lineage and location. , 2009, Immunity.

[25]  B. Medoff,et al.  Contribution of CCR4 and CCR8 to antigen-specific T(H)2 cell trafficking in allergic pulmonary inflammation. , 2009, The Journal of allergy and clinical immunology.

[26]  K. Tamaki,et al.  Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. , 2006, Journal of dermatological science.

[27]  M. Quiding-Järbrink,et al.  Differential expression of chemokine receptors on human IgA+ and IgG+ B cells , 2005, Clinical and experimental immunology.

[28]  R. Jonsson,et al.  Circulating Cytokines in Primary Sjögren's Syndrome Determined by a Multiplex Cytokine Array System , 2004, Scandinavian journal of immunology.

[29]  K. Matsushima,et al.  Increased levels of a TH2‐type CC chemokine thymus and activation‐regulated chemokine (TARC) in serum and induced sputum of asthmatics , 2002, Allergy.

[30]  A. Proudfoot.  Chemokine receptors: multifaceted therapeutic targets , 2002, Nature Reviews Immunology.

[31]  Koichiro Nakamura,et al.  Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. , 2001, The Journal of allergy and clinical immunology.

[32]  I. Homma,et al.  Intervention of Thymus and Activation-Regulated Chemokine Attenuates the Development of Allergic Airway Inflammation and Hyperresponsiveness in Mice1 , 2001, The Journal of Immunology.

[33]  R. Pawankar,et al.  Inducible Expression of a Th2-Type CC Chemokine Thymus- and Activation-Regulated Chemokine by Human Bronchial Epithelial Cells1 , 2000, The Journal of Immunology.

[34]  A. Mantovani,et al.  Identification of the CC chemokines TARC and macrophage inflammatory protein‐1β as novel functional ligands for the CCR8 receptor , 1998, European journal of immunology.

[35]  R. Aalberse,et al.  Allergen‐specific IgG4 in atopic disease , 1993, Allergy.